Turner, R.J.; Guy, T.V.; Geraghty, N.J.; Splitt, A.; Watson, D.; Brungs, D.; Carolan, M.G.; Miller, A.A.; de Leon, J.F.; Aghmesheh, M.;
et al. Low Pretreatment CD4+:CD8+ T Cell Ratios and CD39+CD73+CD19+ B Cell Proportions Are Associated with Improved Relapse-Free Survival in Head and Neck Squamous Cell Carcinoma. Int. J. Mol. Sci. 2023, 24, 12538.
https://doi.org/10.3390/ijms241612538
AMA Style
Turner RJ, Guy TV, Geraghty NJ, Splitt A, Watson D, Brungs D, Carolan MG, Miller AA, de Leon JF, Aghmesheh M,
et al. Low Pretreatment CD4+:CD8+ T Cell Ratios and CD39+CD73+CD19+ B Cell Proportions Are Associated with Improved Relapse-Free Survival in Head and Neck Squamous Cell Carcinoma. International Journal of Molecular Sciences. 2023; 24(16):12538.
https://doi.org/10.3390/ijms241612538
Chicago/Turabian Style
Turner, Ross J., Thomas V. Guy, Nicholas J. Geraghty, Ashleigh Splitt, Debbie Watson, Daniel Brungs, Martin G. Carolan, Andrew A. Miller, Jeremiah F. de Leon, Morteza Aghmesheh,
and et al. 2023. "Low Pretreatment CD4+:CD8+ T Cell Ratios and CD39+CD73+CD19+ B Cell Proportions Are Associated with Improved Relapse-Free Survival in Head and Neck Squamous Cell Carcinoma" International Journal of Molecular Sciences 24, no. 16: 12538.
https://doi.org/10.3390/ijms241612538
APA Style
Turner, R. J., Guy, T. V., Geraghty, N. J., Splitt, A., Watson, D., Brungs, D., Carolan, M. G., Miller, A. A., de Leon, J. F., Aghmesheh, M., & Sluyter, R.
(2023). Low Pretreatment CD4+:CD8+ T Cell Ratios and CD39+CD73+CD19+ B Cell Proportions Are Associated with Improved Relapse-Free Survival in Head and Neck Squamous Cell Carcinoma. International Journal of Molecular Sciences, 24(16), 12538.
https://doi.org/10.3390/ijms241612538
